| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |